Abelmoschus esculentus fractions potently inhibited the pathogenic targets associated with diabetic renal epithelial to mesenchymal transition

Food & Function
Chiung-Huei PengYaw-Bee Ker

Abstract

Although Abelmoschus esculentus (AE) is known for anti-hyperglycemia, few reports have addressed its target. Our recent studies have focused on diabetic renal epithelial to mesenchymal transition (EMT), which plays a critical role in fibrosis that accompanies increasing vimentin and suggested signals DPP-4/AT-1/TGF-β1. This study aimed to investigate whether AE is useful for preventing diabetic renal EMT. We used a succession of extractions and obtained the corresponding fractions F1-F5, each with its own individual properties: F1 inhibits high glucose-stimulated vimentin, AT-1, TGF-β1, and DPP-4, and recovers E-cadherin in tubular cells; F2 decreases high glucose-induced vimentin, AT-1 and DPP-4; F3-F5 do not reduce the expression of vimentin. Chemical analysis revealed that F1 is rich of flavonoid glycosides especially quercetin glucosides, and pentacyclic triterpene ester. F2 contains a large amount of carbohydrates and polysaccharides composed of uronic acid, galactose, glucose, myo-inositol etc. In conclusion, AE has the potential to serve as an adjuvant for diabetic nephropathy, with F1 and F2 especially deserving further investigation and development.

References

Apr 1, 2004·Clinical and Experimental Pharmacology & Physiology·Muragundla Anjaneyulu, Kanwaljit Chopra
Feb 3, 2006·The Journal of Clinical Investigation·Giuseppe RemuzziAndrea Remuzzi
Aug 8, 2006·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·V RavelojaonaL Robert
Aug 22, 2008·Kidney International·Frank M Strutz
Jun 17, 2009·Journal of Cardiovascular Pharmacology·Pitchai BalakumarMadhu B Anand-Srivastava
Jul 17, 2009·Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension·Rigas Kalaitzidis, George L Bakris
Sep 3, 2010·Diabetes/metabolism Research and Reviews·Jun LiuLuyong Zhang
Mar 19, 2011·Diabetic Medicine : a Journal of the British Diabetic Association·F CorradoA Di Benedetto
Nov 30, 2011·PloS One·Lyubov ChaykovskaBerthold Hocher
Oct 30, 2012·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Vinayagam Ramachandran, Ramalingam Saravanan
Jan 18, 2013·Journal of Ayurveda and Integrative Medicine·Vijayakumar SabithaKaliyamoorthy Panneerselvam
Jul 16, 2013·Journal of Agricultural and Food Chemistry·Yi-Sun YangChiung-Huei Peng
Sep 28, 2013·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Jinah ParkSeong-Jin Kim
Oct 1, 2013·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Vinayagam RamachandranPoomalai Senthilraja

❮ Previous
Next ❯

Citations

Mar 30, 2020·Phytotherapy Research : PTR·Danial EsmaeilzadehHossein Hosseinzadeh
Aug 17, 2019·Frontiers in Pharmacology·Lorena Avila-CarrascoGuadalupe González Mateo
Dec 4, 2020·BMC Complementary Medicine and Therapies·Chien-Ning HuangChiung-Huei Peng

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cadherins and Catenins

Cadherins (named for "calcium-dependent adhesion") are a type of cell adhesion molecule (CAM) that is important in the formation of adherens junctions to bind cells with each other. Catenins are a family of proteins found in complexes with cadherin cell adhesion molecules of animal cells: alpha-catenin can bind to β-catenin and can also bind actin. β-catenin binds the cytoplasmic domain of some cadherins. Discover the latest research on cadherins and catenins here.